2022.Mar.17

Announcement of calls on unpaid shares of 2022 cash capital increase

1.Date of occurrence of the event:2022/03/17 2.Company name:OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:Not applicable 5.Cause of occurrence:The payment period for subscription of the Company’s cash capital increase ends on 2022/3/17. The Company makes a call on the shareholders who do not complete the payment […]

HOMEWhat’s NewAnnouncementsAnnouncement of calls on unpaid shares of 2022 cash capital increase

Back to List

This article is password protected.

To view the content, please enter your password in the field below

2022.Feb.23

TFDA has granted the approval for the active cancer immunotherapy OBI-833 to proceed to a Phase II clinical trial

2022.Mar.17

Subscription rights to the cash issue forfeited by directors of the Company reaching 50% and subscription being made available to specific persons